Walgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
Walgreens Infusion Services is recalling 21 famotidine injection syringes compounded by Option Care 148 in Texas due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (sterility issue) where injury has not yet been reported, fitting the High severity criteria.
Plain-English summary
Walgreens Infusion Services is recalling 21 syringes of famotidine injection (10 mg/1 mL and 80 mg/8 mL). The product is prescription-only and was compounded by Option Care 148 in San Antonio, Texas.
The recall was initiated due to a lack of assurance of sterility. The affected lots are all within their expiration dates. The product was distributed in Texas.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions.
The recalled product
- Product
- Famotidine injection syringe a) 10 mg/1 mL b) 80 mg/8 mL, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 21
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 33 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 33 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Sodium Ascorbate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 3-in-1 TPN Formula Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereWalgreens Recalls Ranitidine Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereWalgreens Recalls Folic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- HighInfusion Options Recalls Azacitidine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-21
- SevereWalgreens Recalls Thiamine Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-01-28
- SevereGuardian Pharmacy Recalls Hyaluronidase Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- HighMitomycin Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-11-09